Bipolar Depression Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

(Albany, NY) DelveInsight has launched a new report on “Bipolar Depression Market Insight, Epidemiology and Market Forecast -2030.”

 

DelveInsight's "Bipolar Depression Market Insights and Forecast Report" delivers an in-depth understanding of the Bipolar Depression, historical and forecasted epidemiology as well as the Bipolar Depression market trends, pipeline scenario, Bipolar Depression market drivers, barriers, and forecasted analysis in the 7MM for the study period 2017-30. 

Some of the Facts:

  • ·         As per DelveInsight analysts, the total diagnosed prevalent population of Bipolar Depression in the 7MM was 1,857,545 in 2017.
  • ·         The estimates show the highest diagnosed prevalence of Bipolar Depression in the United States with 740,715 cases in 2017.
  • ·         Bipolar I and Bipolar II are the major subtypes of BD.
  • ·         In 2017, out of the total diagnosed prevalent population of 740,715 cases in the US for Bipolar Depression, 291,134 and 449,581 cases were contributed by Bipolar I disorder and Bipolar II disorder, respectively.

 

Scope of the Report:

  • The Bipolar Depression report covers the descriptive overview of Bipolar Depression, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Bipolar Depression epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Bipolar Depression are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Bipolar Depression market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The Bipolar Depression report provides an edge while developing business strategies, by understanding trends shaping and driving the global Bipolar Depression market

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market

 

Bipolar Depression (Manic depression) is categorized by recurrent-shifts in the mood/temper and is a manic-depressive disorder hindering the routine life of an individual.

The American Psychiatric Association categorizes Bipolar Depression into four major types of Bipolar Depression: Bipolar I disorder, Bipolar II disorder, Cyclothymic disorder, and Bipolar Depression due to another medical or substance abuse disorder.

Bipolar Depression affects about 45 million people worldwide, says WHO.

  

Bipolar Depression Market: Marketed, and Upcoming Drugs

FDA-approved agents for the acute treatment of bipolar depression include Olanzapine-fluoxetine combination, Lurasidone, and Quetiapine.

Other off-label therapies present in the Bipolar Depression market are Anticonvulsants (such as Divalproex and lamotrigine), olanzapine monotherapy, and Lithium and lamotrigine combined therapy.

The Bipolar Depression market report covers detailed picture of marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. The report helps in providing a better understanding of clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market

 

Drugs Covered are:

·         Vraylar (Cariprazine)

·         Latuda (Lurasidone Hydrochloride)

·         Abilify (Aripiprazole)

·          Lumateperone/ITI-007

·         NRX-100/NRX-101

·         Psilocybin

·         Zuranolone (SAGE-217)

·         SEP-4199

·         ILT101

·         Falkieri (Esketamine DPI)

·         And Many Others

 

Some of the Key Companies Covered:

·         Allergan (AbbVie)/Gedeon Richter

·         Sunovion Pharmaceuticals (Sumitomo Dainippon Pharma)

·         Otsuka Pharmaceutical

·         Intra-cellular Therapies

·         NeuroRx

·         COMPASS Pathways

·         Sage Therapeutics

·         Sunovion/Sumitomo Dainippon Pharma

·         Iltoo Pharma

·         Celon Pharma

·         And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market

  

Bipolar Depression Report Highlights

  • Dynamic Bipolar Depression market trends
  • Healthcare spending fuelling Bipolar Depression Market
  • Collaborations, mergers, and acquisitions in   Market
  • Challenges poised and opportunities present influencing Bipolar Depression Market
  • R&D driving   Market 
  • Novel therapies and drugs in Bipolar Depression pipeline
  • Major players involved impacting Bipolar Depression    market
  • In-depth analysis of the pipeline products (Phase III and Phase II), comparative analysis with detailed clinical profiles, key cross-competition, launch date along with product development activities

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market

 

Table of Contents

1. Key Insights

2. Executive Summary of Bipolar Depression   

3. Competitive Intelligence Analysis for Bipolar Depression   

4. Bipolar Depression: Market Overview at a Glance

5. Bipolar Depression: Disease Background and Overview

6. Patient Journey

7. Bipolar Depression Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Bipolar Depression Treatment

11. Marketed Products

12. Emerging Therapies

13. Bipolar Depression: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Bipolar Depression   

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

Request for Detailed TOC: https://www.delveinsight.com/sample-request/bipolar-disorder-manic-depression-market

 

 

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for

Browse through our vast repository from here.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Bipolar Depression market,Bipolar Depression market research,Bipolar Depression market insight,Bipolar Depression market trends,Bipolar Depression market forecast,Bipolar Depression market share,Bipolar Depression pipeline drugs,Bipolar Depression treatment algorithm,Bipolar Depression drugs,Bipolar Depression sales forecasting,Bipolar Depression market size,Bipolar Depression disease,Bipolar Depression epidemiology,Bipolar Depression

 


Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Hypothalamic Obesity Market by DelveInsight

  (New York, USA) DelveInsight’s “ Hypothalamic Obesity Market Insights, Epidemiology, and Market Forecast-2032 ” report delivers an in-depth understanding of Hypothalamic Obesity, historical and forecasted epidemiology as well as the Hypothalamic Obesity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Hypothalamic Obesity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Hypothalamic Obesity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Hypothalamic Obesity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Hypothalamic Obesity market. Request for a Free Sample Report @  Hypothalamic Obesity Market Forecast Some facts of the Hypothalamic Obesity Market Report are: Accordi
Read more

Vernal Keratoconjunctivitis Market

(Albany, US) DelveInsight’s “ Vernal Keratoconjunctivitis Market  Insights, Epidemiology, and Market Forecast-2030 ” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Vernal Keratoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the key facts of the  Vernal Keratoconjunctivitis Market The increasing population and rising prevalence of Vernal Keratoconjunctivitis generates a large patient population in the global market. In 2017, a total of 4,752,356 patients were affected by Vernal Keratoconjunctivitis in the global market. China contributes the largest share among EU-5, and Japan, with 2,248,706 cases in 2017. The total diagnosed prevalent population of Vernal Keratoconjunctivitis was 2,943,057 in the global market.   Request for Sample Report: https://www.delveinsight.com/report-store/vernal-kerato
Read more